Tafasitamab,Lenalidomide
Morphosys,Incyte
['dlbcl', 'firstmind', 'lymphoma', 'morphosys']
a final analysis from the phase 1b firstmind trial at #ash22 indicates that one of our investigational compounds has the potential to help treat patients with newly diagnosed diffuse large b-cell lymphoma (#dlbcl). learn more: 
Global commercial-stage biopharmaceutical company driven by our mission: More life for people with cancer.